Imunon, Inc. (IMNN) vs Lunai Bioworks Inc. (LNAI)

A side-by-side comparison of Imunon, Inc. and Lunai Bioworks Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

IMNN

Imunon, Inc.

$5M

$1.20HealthcareDelayed quote: Oct 6, 2026, 12:27 PM EDT

LNAI

Lunai Bioworks Inc.

$5M

$1.15HealthcareDelayed quote: Oct 6, 2026, 12:28 PM EDT

Total return — IMNN vs LNAI

growth of $100 · dividends reinvested · last 1y

IMNN -80.1% (-80.1%/yr)LNAI -93.8% (-93.8%/yr)IMNN compounded faster over this window

IMNN LNAI

IMNN vs LNAI: by the numbers

•LNAI is the larger company ($5M vs $5M market cap).
•Both run net losses; IMNN's is the smaller (0.00% vs -612568.11% net margin).

Metrics side by side

Valuation

Metric	IMNN	LNAI
P/S ratio	N/A	248.97
P/B ratio	1.20	N/A

Profitability

Metric	IMNN	LNAI
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	-612568.11%
ROE	-351.30%	N/A
ROIC	-126.69%	N/A

Growth (annualized)

Metric	IMNN	LNAI
Total return CAGR (5Y)	-63.83%	N/A

Go deeper

Full IMNN analysis Full LNAI analysis Interactive comparison tool

Dig into the metrics

Imunon ROE Lunai Bioworks ROE Imunon operating margin Lunai Bioworks operating margin Imunon revenue growth Lunai Bioworks revenue growth Imunon free cash flow Lunai Bioworks free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.